Federation des caisses Desjardins du Quebec’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-650	Closed	-$2.4K	–	2255
2017 Q4	$2.4K	Hold	650	–	–	﹤0.01%	1975
2017 Q3	$2.66K	Hold	650	–	–	﹤0.01%	1914
2017 Q2	$2.42K	Hold	650	–	–	﹤0.01%	1992
2017 Q1	$2.69K	Buy	+650	New	+$2.73K	﹤0.01%	1630

Federation des caisses Desjardins du Quebec's CASC Position: Q1 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 650 shares — an estimated $2.4K sold.

Federation des caisses Desjardins du Quebec first reported a position in CASC in Q1 2017 and held it in 4 quarters. The position peaked at $2.69K in Q1 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

Federation des caisses Desjardins du Quebec reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 650 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $2.4K.
Federation des caisses Desjardins du Quebec first reported a position in Cascadian Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
Federation des caisses Desjardins du Quebec's Cascadian Therapeutics, Inc. position peaked at $2.69K in Q1 2017.
1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2018, filed 30 Aug 2024.